ID   UMJF-2
AC   CVCL_M548
DR   Wikidata; Q54991076
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=1649357;
RX   PubMed=10936422;
CC   Problematic cell line: Misclassified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line (PubMed=10936422).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
RX   DOI=10.1007/0-306-46877-8_4;
RA   Jernberg-Wiklund H., Nilsson K.;
RT   "Multiple myeloma cell lines.";
RL   (In) Human cell culture. Vol. 3. Cancer Cell Lines part 3; Masters J.R.W., Palsson B.O. (eds.); pp.81-155; Kluwer Academic Publishers; New York (2000).
//
RX   PubMed=1649357;
RA   Farnen J.P., Tyrkus M., Hanson C.A., Cody R.L., Emerson S.G.;
RT   "Characterization of a new human multiple myeloma cell line, UMJF-2,
RT   which suppresses antibody production by B-lymphocytes in vitro.";
RL   Leukemia 5:574-584(1991).
//
RX   PubMed=10936422; DOI=10.1016/S0145-2126(99)00195-2;
RA   Drexler H.G., Matsuo Y.;
RT   "Malignant hematopoietic cell lines: in vitro models for the study of
RT   multiple myeloma and plasma cell leukemia.";
RL   Leuk. Res. 24:681-703(2000).
//